In this article for PharmaTimes Magazine, Phastar’s Elisa Mansfield discusses the rising popularity and benefits of the Functional Service Provider (FSP) model in the pharmaceutical industry. With growing complexities in clinical trials and increasing demands for expertise, the FSP model allows sponsors to engage specialized services when needed.
Read the full article in PharmaTimes Magazine.